Authors: TAYLOR DL AHMED PS BRENNAN TM BRIDGES CG TYMS AS VANDORSSELAER V TARNUS C HORNSPERGER JM SCHIRLIN D

Citation: Dl. Taylor et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, BIOAVAILABILITY AND DRUG-RESISTANCE PROFILE OF THE NOVEL PROTEINASE-INHIBITOR MDL-74,695, Antiviral chemistry & chemotherapy, 8(3), 1997, pp. 205-214

Authors: VANDORSSELAER V SCHIRLIN D MARCHAL P WEBER F DANZIN C

Citation: V. Vandorsselaer et al., SILICON-MEDIATED INACTIVATION OF DIAMINE OXIDASE, Bioorganic chemistry, 24(2), 1996, pp. 178-193

Authors: SCHIRLIN D VANDORSSELAER V TARNUS C TAYLOR DL TYMS AS BALTZER S WEBER F REMY JM BRENNAN T FARR R JANOWICK D

Citation: D. Schirlin et al., BENEFICIAL REPLACEMENT OF THE P-1 PHENYLALANINE SIDE-CHAIN IN HIV-1 PROTEASE INHIBITORS OF THE DIFLUOROSTATONE TYPE, Bioorganic & medicinal chemistry letters, 4(2), 1994, pp. 241-246

Authors: VANDORSSELAER V SCHIRLIN D TARNUS C TAYLOR DL TYMS AS WEBER F BALTZER S REMY JM BRENNAN T JANOWICK D

Citation: V. Vandorsselaer et al., INCREASED ANTIVIRAL ACTIVITY OF HIV PROTEASE INHIBITORS OF THE DIFLUOROSTATONE TYPE BEARING (R)-VALINOL DERIVATIVES AS NOVEL C-TERMINI, Bioorganic & medicinal chemistry letters, 4(10), 1994, pp. 1213-1218